Here are five things to know:
1. The House approved the bill last week with a majority vote. The bill now needs a signature from President Barack Obama before coming to fruition.
2. The Senate passed the act with an 85-13 majority vote.
3. The bill, valued at $6.3 billion, has the Obama administration’s support. On Nov. 30, 2016, the White House published a press release stating, “Like all comprehensive legislation, the bill is not perfect, and there are provisions the administration would prefer were improved, but the legislation offers advances in health that far outweigh these concerns. The Senate should promptly pass this bill so that the President can sign it.”
4. The 21st Century Cures Act changes various FDA requirements that will demand fewer studies from drug companies for product approval. Additionally, the bill allots $4.8 billion over the next decade in additional National Institutes of Health funding.
5. Various consumer and patient advocacy groups have opposed parts of the bill, saying it enables the approval of unsafe drugs and devices.
More articles on practice management:
Harvard Medical School names Dr. James Kang inaugural Thornhill Family Professor of Orthopedic Surgery: 4 notes
Cedar Valley Medical Specialists: A 65-yr+ family business model
5 health IT predictions for 2017
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
